Stephen B. Heitner
About
In The Last Decade
Stephen B. Heitner
77 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 756
- Molecular Biology 491
- Epidemiology 174
- Oncology 127
- Physiology 105
Countries citing papers authored by Stephen B. Heitner
This map shows the geographic impact of Stephen B. Heitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Heitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Heitner more than expected).
Fields of papers citing papers by Stephen B. Heitner
This network shows the impact of papers produced by Stephen B. Heitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Heitner. The network helps show where Stephen B. Heitner may publish in the future.
Co-authorship network of co-authors of Stephen B. Heitner
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen B. Heitner. A scholar is included among the top collaborators of Stephen B. Heitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen B. Heitner. Stephen B. Heitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 10 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | Abstract 14214: ATTRibute-CM: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Phase 3 Study of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 5 |
| 11 | Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy | 5 |
| 12 | Abstract 13962: Precision Pharmacological Treatment for Obstructive Hypertrophic Cardiomyopathy With Mavacamten: One-Year Results From PIONEER-OLE | 4 |
| 13 | 180 | |
| 14 | 4 | |
| 15 | 32 | |
| 16 | Abstract 16466: EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy | 2 |
| 17 | 18 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.